4/6/2023 1:14:47 AM
Gerresheimer Q1 Revenues EUR 457.8 Mln Vs EUR 370.8 Mln Last Year
2/23/2023 1:05:09 AM
Gerresheimer Posts Q4 Revenues Of EUR 529 Mln, Representing Organic Growth Of 15.9%
12/6/2022 8:30:34 AM
Gerresheimer Says Guiding For Double-digit Organic Growth In Both Revenues And Adj. EBITDA
10/27/2022 4:35:17 AM
Gerresheimer And Merck Develop Digital Twins For Primary Packaging
10/12/2022 1:02:33 AM
Gerresheimer Q3 Revenues Up Organically By 17.4% To EUR 473 Mln
9/7/2022 2:02:25 AM
Gerresheimer, Stevanato Group Announce Collaboration On Development Of Innovative Ready-To-Use Vial Platform
8/17/2022 2:38:40 AM
Gerresheimer, Zollner Enter Strategic Partnership For Electronically Controlled Medtech Systems
7/13/2022 2:41:33 AM
Gerresheimer Reaffirms Guidance For Its Financial Year 2022
7/13/2022 1:02:46 AM
Gerresheimer Q2 EPS EUR 0.80; Adj EPS EUR 1.34
6/8/2022 8:53:33 AM
Gerresheimer AGM Approves Dividend Of EUR 1.25/shr
4/7/2022 1:29:16 AM
Gerresheimer Q1 Revenue Up Organically By 19.1%